{"product_id":"pacira-business-model-canvas","title":"Pacira Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePacira's Business Model Unveiled\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover the core elements of Pacira's innovative business model. This Business Model Canvas breaks down how they deliver value and engage their target markets. Perfect for anyone looking to understand their competitive edge.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Providers and Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePacira strategically partners with hospitals, ambulatory surgery centers (ASCs), and individual healthcare practitioners (HCPs). These collaborations are vital for embedding EXPAREL and iovera° into established pain management pathways, thereby promoting the adoption of non-opioid alternatives for post-surgical pain.\u003c\/p\u003e\n\u003cp\u003eThe upcoming NOPAIN Act, slated for implementation in 2025, is anticipated to significantly boost the use of EXPAREL and iovera°. This legislation will broaden patient access to these innovative treatments, particularly within outpatient environments, reinforcing their role in multimodal pain management strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGroup Purchasing Organizations (GPOs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrategic agreements with Group Purchasing Organizations (GPOs), like Premier, Inc., are crucial for Pacira. These partnerships enable Pacira to provide preferential pricing and contract terms for its innovative products to a vast network of hospitals and healthcare systems across the United States. This access is instrumental in expanding market reach and promoting cost savings for healthcare providers, ultimately boosting product adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePacira actively pursues research and development collaborations to push the boundaries of non-opioid pain management and related musculoskeletal fields. These partnerships are crucial for both acquiring new scientific knowledge and developing innovative therapeutic assets.\u003c\/p\u003e\n\u003cp\u003eThe company engages in co-development agreements and other shared initiatives, exemplified by its acquisition of GQ Bio Therapeutics. This strategic move integrated a novel gene therapy platform into Pacira's pipeline, underscoring the value placed on external innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical and MedTech Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePacira BioSciences actively cultivates partnerships with other pharmaceutical and medical technology firms to amplify its market presence. A prime example is the strategic co-promotion agreement inked in 2023 with Johnson \u0026amp; Johnson MedTech for ZILRETTA. This collaboration is designed to harness J\u0026amp;J's established sales force and deep market expertise, aiming to introduce ZILRETTA to a broader array of physician specialties and enhance its promotional reach.\u003c\/p\u003e\n\u003cp\u003eThese alliances are crucial for Pacira, allowing it to leverage the existing infrastructure and specialized knowledge of its partners. By doing so, Pacira can more effectively penetrate new market segments and reach healthcare providers who might otherwise be difficult to access. This approach not only expands the promotional footprint of its products but also accelerates market adoption through shared resources and complementary capabilities.\u003c\/p\u003e\n\u003cp\u003eThe benefits of such partnerships are multifaceted:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpanded Market Reach:\u003c\/strong\u003e Collaborations allow Pacira to tap into established distribution channels and customer bases of its partners, significantly broadening its market penetration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnhanced Promotional Efforts:\u003c\/strong\u003e Leveraging the sales forces and marketing expertise of companies like Johnson \u0026amp; Johnson MedTech amplifies the promotional impact for Pacira's products.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAccess to New Specialties:\u003c\/strong\u003e Partnerships facilitate entry into physician specialties that Pacira might not have direct access to, thereby diversifying its customer base.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResource Optimization:\u003c\/strong\u003e Co-promotion agreements enable efficient use of resources by sharing promotional costs and sales efforts, leading to a more cost-effective market strategy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Clinical Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePacira BioSciences actively collaborates with academic and clinical research institutions to advance the understanding and application of its pain management solutions. These partnerships are crucial for funding and conducting investigator-initiated trials (IITs). These trials delve into the safety, efficacy, and pharmacological profiles of Pacira's existing products.\u003c\/p\u003e\n\u003cp\u003eThese collaborations are instrumental in generating robust evidence that further validates the clinical utility of Pacira's non-opioid pain therapies. This evidence is vital for informing healthcare providers and payers, ultimately supporting broader adoption of these innovative treatments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eInvestigator-Initiated Trials (IITs):\u003c\/strong\u003e Pacira supports research led by independent investigators at leading academic centers, focusing on novel applications and deeper insights into their pain management portfolio.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvidence Generation:\u003c\/strong\u003e Partnerships contribute to a growing body of clinical data, reinforcing the value proposition of non-opioid alternatives in various surgical and medical settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharmacology and Safety Studies:\u003c\/strong\u003e Collaborations enable detailed investigations into how Pacira's products work and their long-term safety profiles, building confidence among the medical community.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKey Partnerships Drive Non-Opioid Pain Therapy Adoption\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePacira's key partnerships extend to Group Purchasing Organizations (GPOs) and other pharmaceutical firms, such as its 2023 co-promotion agreement with Johnson \u0026amp; Johnson MedTech for ZILRETTA. These alliances are crucial for expanding market reach and leveraging established sales forces, accelerating product adoption. Furthermore, collaborations with academic and clinical research institutions, supported by investigator-initiated trials, generate vital evidence validating non-opioid pain therapies, crucial for provider and payer acceptance.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eExample Partner\u003c\/th\u003e\n\u003cth\u003ePurpose\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals \u0026amp; ASCs\u003c\/td\u003e\n\u003ctd\u003eVarious Healthcare Facilities\u003c\/td\u003e\n\u003ctd\u003eEmbed EXPAREL and iovera° into pain management pathways\u003c\/td\u003e\n\u003ctd\u003ePromotes non-opioid alternative adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPOs\u003c\/td\u003e\n\u003ctd\u003ePremier, Inc.\u003c\/td\u003e\n\u003ctd\u003eProvide preferential pricing and contract terms\u003c\/td\u003e\n\u003ctd\u003eExpands market reach and promotes cost savings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharma\/MedTech\u003c\/td\u003e\n\u003ctd\u003eJohnson \u0026amp; Johnson MedTech\u003c\/td\u003e\n\u003ctd\u003eCo-promotion of ZILRETTA\u003c\/td\u003e\n\u003ctd\u003eLeverages established sales force and market expertise\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch Institutions\u003c\/td\u003e\n\u003ctd\u003eAcademic Medical Centers\u003c\/td\u003e\n\u003ctd\u003eSupport Investigator-Initiated Trials (IITs)\u003c\/td\u003e\n\u003ctd\u003eGenerates evidence for product validation and adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA detailed Pacira Business Model Canvas outlines its focus on developing and commercializing non-opioid pain management solutions, targeting healthcare providers and patients through a direct sales force and strategic partnerships.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003ePacira's Business Model Canvas acts as a pain point reliever by offering a clear, one-page snapshot of their strategy, allowing for rapid identification of key value propositions and customer segments that address unmet needs in pain management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePacira's core activity revolves around robust research and development, focusing on creating novel non-opioid pain management solutions. This includes expanding the applications for their established products like EXPAREL and PCRX-201, ensuring continued market relevance and growth.\u003c\/p\u003e\n\u003cp\u003eThe company actively advances its innovative pipeline, featuring promising programs in clinical development. A key area of focus is gene therapy aimed at addressing musculoskeletal pain, alongside exploring related adjacencies to broaden their therapeutic reach.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePacira BioSciences is directly involved in manufacturing its specialized pharmaceutical products, notably EXPAREL, which requires intricate liposomal formulation processes. This hands-on approach to production underscores their commitment to quality and control over their unique drug delivery system.\u003c\/p\u003e\n\u003cp\u003eEffective supply chain management is crucial for Pacira, ensuring that healthcare providers consistently receive their products without interruption. This reliability is paramount for patient care and the company's market reputation.\u003c\/p\u003e\n\u003cp\u003eIn 2023, Pacira reported revenue of $575.2 million, a significant increase from $452.5 million in 2022, reflecting strong demand for its products and successful execution of its manufacturing and supply chain strategies. The company is actively investing in expanding its manufacturing capabilities, including larger manufacturing suites, to enhance gross margins and effectively meet the escalating demand for its innovative therapies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercialization and Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePacira's commercialization and sales activities are centered on promoting its key products, EXPAREL, ZILRETTA, and iovera°, to healthcare professionals and institutions. This is achieved through a dedicated direct sales force that engages with physicians, hospitals, and ambulatory surgery centers.\u003c\/p\u003e\n\u003cp\u003eEducational campaigns play a crucial role in driving product adoption, highlighting the clinical benefits and economic advantages of Pacira's offerings. These efforts aim to increase market share, particularly within the acute care setting, where pain management is a critical component of patient recovery and satisfaction.\u003c\/p\u003e\n\u003cp\u003eStrategic partnerships are also leveraged to expand reach and enhance market penetration. For instance, in 2024, Pacira continued to focus on expanding access to EXPAREL in various surgical specialties and reinforced its commitment to ZILRETTA for osteoarthritis knee pain, aiming for continued growth in these key therapeutic areas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Affairs and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePacira's key activities heavily involve navigating the intricate regulatory environments of health authorities, most notably the U.S. Food and Drug Administration (FDA). This includes the critical process of securing and maintaining product approvals, ensuring all products meet stringent safety and efficacy standards. For instance, the company's commitment to compliance is a continuous effort, especially as new data emerges and regulations evolve.\u003c\/p\u003e\n\u003cp\u003eA significant portion of Pacira's efforts is dedicated to intellectual property management. This encompasses the strategic filing of patent applications to protect its innovative technologies and products, as well as engaging in patent litigation when necessary to defend its proprietary rights. This proactive approach safeguards their market position and encourages further research and development.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory Navigation:\u003c\/strong\u003e Pacira actively manages compliance with health authorities like the FDA to ensure all products meet rigorous standards.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct Approvals:\u003c\/strong\u003e Securing and maintaining necessary product approvals is a core function, vital for market access and patient safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntellectual Property Protection:\u003c\/strong\u003e Pacira engages in patent applications and litigation to safeguard its unique technologies and product innovations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket Access and Reimbursement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePacira BioSciences actively works to ensure favorable reimbursement pathways for its non-opioid pain management therapies. This is crucial for expanding patient access and involves direct engagement with government agencies, private insurers, and Group Purchasing Organizations (GPOs) to secure appropriate coverage and pricing.  A key focus for 2024 and beyond is the continued advocacy and implementation of policies like the NOPAIN Act, which aims to incentivize the use of non-opioid alternatives.\u003c\/p\u003e\n\u003cp\u003eSecuring positive coverage decisions and favorable pricing is a continuous effort. For instance, in 2023, Pacira reported ongoing discussions with payers to ensure ExpaRel (bupivacaine liposome injectable suspension) is recognized and reimbursed effectively. This strategic activity directly impacts the commercial viability and adoption of their innovative pain management solutions.\u003c\/p\u003e\n\u003cp\u003eKey activities in this area include:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eEngaging with policymakers:\u003c\/strong\u003e Actively participating in discussions and providing data to support legislation like the NOPAIN Act, which promotes non-opioid pain management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNegotiating with payers:\u003c\/strong\u003e Working with commercial insurers and Medicare\/Medicaid to establish favorable reimbursement rates and formulary placement for their products.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePartnering with GPOs and IDNs:\u003c\/strong\u003e Collaborating with healthcare systems and purchasing groups to streamline access and procurement processes for their therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHealth economics and outcomes research (HEOR):\u003c\/strong\u003e Generating and disseminating data that demonstrates the value and cost-effectiveness of their non-opioid solutions to payers and providers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKey Activities in Non-Opioid Pain Management Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePacira's key activities center on developing and commercializing non-opioid pain management solutions, with a strong emphasis on research and development for novel therapies and expanding the utility of existing products like EXPAREL.  This includes advancing their pipeline, particularly gene therapy for musculoskeletal pain, and manufacturing their specialized pharmaceutical products, such as EXPAREL's complex liposomal formulation.  The company also focuses on robust supply chain management to ensure product availability and engages in direct sales force activities to promote EXPAREL, ZILRETTA, and iovera° to healthcare providers.\u003c\/p\u003e\n\u003cp\u003eFurthermore, Pacira actively navigates regulatory landscapes, securing and maintaining product approvals from authorities like the FDA, and diligently manages its intellectual property through patent filings and litigation. A critical ongoing activity involves securing favorable reimbursement pathways for its therapies by engaging with payers, policymakers, and healthcare systems, supported by health economics and outcomes research to demonstrate product value.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eKey Activity Area\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003e2023\/2024 Focus\/Data\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch \u0026amp; Development\u003c\/td\u003e\n\u003ctd\u003eInnovating non-opioid pain management solutions, expanding product applications.\u003c\/td\u003e\n\u003ctd\u003eAdvancing gene therapy pipeline; continued EXPAREL and PCRX-201 development.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing\u003c\/td\u003e\n\u003ctd\u003eProducing specialized pharmaceutical products with complex formulations.\u003c\/td\u003e\n\u003ctd\u003eInvesting in expanded manufacturing capabilities to meet demand and improve gross margins.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCommercialization \u0026amp; Sales\u003c\/td\u003e\n\u003ctd\u003ePromoting EXPAREL, ZILRETTA, iovera° to healthcare professionals.\u003c\/td\u003e\n\u003ctd\u003eDirect sales force engagement; expanding access in surgical specialties and osteoarthritis treatment.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory \u0026amp; IP Management\u003c\/td\u003e\n\u003ctd\u003eNavigating FDA approvals; protecting intellectual property.\u003c\/td\u003e\n\u003ctd\u003eEnsuring compliance with evolving regulations; defending patent rights.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReimbursement \u0026amp; Market Access\u003c\/td\u003e\n\u003ctd\u003eSecuring favorable coverage and pricing for therapies.\u003c\/td\u003e\n\u003ctd\u003eAdvocating for policies like the NOPAIN Act; negotiating with payers and GPOs.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Pacira Business Model Canvas preview you are seeing is the actual document you will receive upon purchase. This means the structure, formatting, and content displayed are precisely what you will download, ensuring no discrepancies or missing elements. You can confidently evaluate the quality and completeness of the Business Model Canvas based on this direct representation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55538339283321,"sku":"pacira-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/pacira-business-model-canvas.png?v=1753618989","url":"https:\/\/portersfiveforce.com\/products\/pacira-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}